Estrogen ameliorates microglial activation by inhibiting the Kir2.1 inward-rectifier K+ channel

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Wu, Shih Ying ^a   Chen, Yun Wen ^a,b   Tsai, Sheng Feng ^a   Wu, Sheng Nan ^a   Shih, Yao Hsiang ^a   Jiang Shieh, Ya Fen ^a   Yang, Ting Ting ^b   Kuo, Yu Min ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; INWARDLY RECTIFYING POTASSIUM CHANNEL; LIPOPOLYSACCHARIDE;

AGE; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; C57BL MOUSE; CELL COUNT; CELL LINE; CYTOLOGY; DOPAMINERGIC NERVE CELL; DRUG EFFECTS; FEMALE; MALE; METABOLISM; MICROGLIA; OVARIECTOMY; SEX DIFFERENCE; SUBSTANTIA NIGRA;

AGE FACTORS; ANIMALS; CELL COUNT; CELL LINE; DOPAMINERGIC NEURONS; ESTRADIOL; ESTROGENS; FEMALE; LIPOPOLYSACCHARIDES; MALE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICROGLIA; OVARIECTOMY; POTASSIUM CHANNELS, INWARDLY RECTIFYING; SEX FACTORS; SUBSTANTIA NIGRA;

EID: 84960911907     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep22864     Document Type: Article

References (58)

1. Sulzer, D. Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease. Trends Neurosci. 30, 244-250 (2007).
2. Tansey, M. G. & Goldberg, M. S. Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis. 37, 510-518 (2010).
3. Tanner, C. M. Is the cause of Parkinson's disease environmental or hereditary? Evidence from twin studies. Adv Neurol. 91, 133-142 (2003).
4. Lee, J. K., Tran, T. & Tansey, M. G. Neuroinflammation in Parkinson's disease. J Neuroimmune Pharmacol. 4, 419-429 (2009).
5. McGeer, P. L., Itagaki, S., Boyes, B. E. & McGeer, E. G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38, 1285-1291 (1988).
6. Ouchi, Y. et al. Microglial activation and dopamine terminal loss in early Parkinson's disease. Ann Neurol. 57, 168-175 (2005).
7. Herrera, A. J., Castano, A., Venero, J. L., Cano, J. & Machado, A. The single intranigral injection of LPS as a new model for studying the selective effects ofinflammatory reactions on dopaminergic system. Neurobiol Dis. 7, 429-447 (2000).
8. Gao, H. M. et al. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J Neurochem. 81, 1285-1297 (2002).
9. Hauss-Wegrzyniak, B., Vannucchi, M. G. & Wenk, G. L. Behavioral and ultrastructural changes induced by chronic neuroinflammation in young rats. Brain Res. 859, 157-166 (2000).
10. Sui, Y., Stanic, D., Tomas, D., Jarrott, B. & Horne, M. K. Meloxicam reduces lipopolysaccharide-induced degeneration of dopaminergic neurons in the rat substantia nigra pars compacta. Neurosci Lett. 460, 121-125 (2009).
11. Chen, H. L. et al. Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease. Ann Neurol. 58, 963-967 (2005).
12. Esposito, E. et al. Non-steroidal anti-inflammatory drugs in Parkinson's disease. Exp Neurol. 205, 295-312 (2007).
13. Diamond, S. G., Markham, C. H., Hoehn, M. M., McDowell, F. H. & Muenter, M. D. An examination of male-female differences in progression and mortality of Parkinson's disease. Neurology 40, 763-766 (1990).
14. Baldereschi, M. et al. Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology 55, 1358-1363 (2000).
15. Wang, S., Ren, P., Li, X., Guan, Y. & Zhang, Y. A. 17beta-estradiol protects dopaminergic neurons in organotypic slice of mesencephalon by MAPK-mediated activation of anti-apoptosis gene BCL2. J Mol Neurosci. 45, 236-245 (2011).
16. Wu, T. W., Wang, J. M., Chen, S. & Brinton, R. D. 17Beta-estradiol induced Ca2+ influx via L-type calcium channels activates the Src/ERK/cyclic-AMP response element binding protein signal pathway and BCL-2 expression in rat hippocampal neurons: a potential initiation mechanism for estrogen-induced neuroprotection. Neuroscience 135, 59-72 (2005).
17. McDermott, J. L. Effects of estrogen upon dopamine release from the corpus striatum of young and aged female rats. Brain Res. 606, 118-125 (1993).
18. Sellers, K. J. et al. Rapid modulation of synaptogenesis and spinogenesis by 17beta-estradiol in primary cortical neurons. Front Cell Neurosci. 9, 137 (2015).
19. Nimmerjahn, A., Kirchhoff, F. & Helmchen, F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314-1318 (2005).
20. Hanisch, U. K. & Kettenmann, H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci. 10, 1387-1394 (2007).
21. Stence, N., Waite, M. & Dailey, M. E. Dynamics of microglial activation: A confocal time-lapse analysis in hippocampal slices. Glia 33, 256-266 (2001).
22. Kettenmann, H., Hanisch, U. K., Noda, M. & Verkhratsky, A. Physiology of microglia. Physiol Rev. 91, 461-553 (2011).
23. Wang, X. J. et al. Impaired CD200-CD200R-mediated microglia silencing enhances midbrain dopaminergic neurodegeneration: roles of aging, superoxide, NADPH oxidase, and p38 MAPK. Free Radic Biol Med. 50, 1094-1106 (2011).
24. Colton, C. A., Jia, M., Li, M. X. & Gilbert, D. L. K+ modulation of microglial superoxide production: involvement of voltage-gated Ca2+ channels. Am J Physiol. 266, C1650-1655 (1994).
25. Sierra, A., Gottfried-Blackmore, A., Milner, T. A., McEwen, B. S. & Bulloch, K. Steroid hormone receptor expression and function in microglia. Glia 56, 659-674 (2008).
26. Saijo, K., Collier, J. G., Li, A. C., Katzenellenbogen, J. A. & Glass, C. K. An ADIOL-ERbeta-CtBP transrepression pathway negatively regulates microglia-mediated inflammation. Cell 145, 584-595 (2011).
27. Vegeto, E. et al. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J Neurosci. 21, 1809-1818 (2001).
28. Kim, W. G. et al. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: Role of microglia. J Neurosci. 20, 6309-6316 (2000).
29. Tsai, K. L., Chang, H. F. & Wu, S. N. The inhibition of inwardly rectifying K+ channels by memantine in macrophages and microglial cells. Cell Physiol Biochem. 31, 938-951 (2013).
30. Hibino, H. et al. Inwardly rectifying potassium channels: their structure, function, and physiological roles. Physiol Rev. 90, 291-366 (2010).
31. Qin, L., Liu, Y., Hong, J. S. & Crews, F. T. NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration. Glia 61, 855-868 (2013).
32. Hefendehl, J. K. et al. Homeostatic and injury-induced microglia behavior in the aging brain. Aging Cell. 13, 60-69 (2014).
33. Bardou, I. et al. Age and duration of inflammatory environment differentially affect the neuroimmune response and catecholaminergic neurons in the midbrain and brainstem. Neurobiol Aging 35, 1065-1073 (2014).
34. Gao, H. M. et al. Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration. J Neurosci. 28, 7687-7698 (2008).
35. Wu, S. Y. et al. Running exercise protects the substantia nigra dopaminergic neurons against inflammation-induced degeneration via the activation of BDNF signaling pathway. Brain Behav Immun. 25, 135-146 (2011).
36. Sribnick, E. A. et al. Estrogen attenuated markers of inflammation and decreased lesion volume in acute spinal cord injury in rats. J Neurosci Res. 82, 283-293 (2005).
37. Gold, S. M. & Voskuhl, R. R. Estrogen treatment in multiple sclerosis. J Neurol Sci. 286, 99-103 (2009).
38. Ito, A. et al. Estrogen treatment down-regulates TNF-alpha production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J Immunol. 167, 542-552 (2001).
39. Murphy, A. J., Guyre, P. M. & Pioli, P. A. Estradiol suppresses NF-kappa B activation through coordinated regulation of let-7a and miR-125b in primary human macrophages. J Immunol. 184, 5029-5037 (2010).
40. Boucsein, C., Kettenmann, H. & Nolte, C. Electrophysiological properties of microglial cells in normal and pathologic rat brain slices. Eur J Neurosci. 12, 2049-2058 (2000).
41. Franchini, L., Levi, G. & Visentin, S. Inwardly rectifying K+ channels influence Ca2+ entry due to nucleotide receptor activation in microglia. Cell Calcium. 35, 449-459 (2004).
42. Takenouchi, T., Sato, M. & Kitani, H. Lysophosphatidylcholine potentiates Ca2+ influx, pore formation and p44/42 MAP kinase phosphorylation mediated by P2X7 receptor activation in mouse microglial cells. J Neurochem. 102, 1518-1532 (2007).
43. Cui, J., Shen, Y. & Li, R. Estrogen synthesis and signaling pathways during aging: from periphery to brain. Trends Mol Med. 19, 197-209 (2013).
44. Gerstner, B. et al. 17beta-estradiol protects against hypoxic/ischemic white matter damage in the neonatal rat brain. J Neurosci Res. 87, 2078-2086 (2009).
45. Romanenko, V. G., Rothblat, G. H. & Levitan, I. Modulation of endothelial inward-rectifier K+ current by optical isomers of cholesterol. Biophys J. 83, 3211-3222 (2002).
46. Ghisletti, S., Meda, C., Maggi, A. & Vegeto, E. 17beta-estradiol inhibits inflammatory gene expression by controlling NF-kappaB intracellular localization. Mol Cell Biol. 25, 2957-2968 (2005).
47. Vegeto, E. et al. Regulation of the lipopolysaccharide signal transduction pathway by 17beta-estradiol in macrophage cells. J Steroid Biochem Mol Biol. 91, 59-66 (2004).
48. Vegeto, E. et al. Estrogen receptor-alpha mediates the brain antiinflammatory activity of estradiol. Proc Natl Acad Sci USA 100, 9614-9619 (2003).
49. Yang, T. T. et al. Differential distribution and activation of microglia in the brain of male C57BL/6J mice. Brain Struct Funct. 218, 1051-1060 (2013).
50. Schlichter, L. C., Sakellaropoulos, G., Ballyk, B., Pennefather, P. S. & Phipps, D. J. Properties of K+ and Cl-channels and their involvement in proliferation of rat microglial cells. Glia 17, 225-236 (1996).
51. Amigorena, S., Choquet, D., Teillaud, J. L., Korn, H. & Fridman, W. H. Ion channel blockers inhibit B cell activation at a precise stage of the G1 phase of the cell cycle. Possible involvement of K+ channels. J Immunol. 144, 2038-2045 (1990).
52. Zhang, Q. G. et al. Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation. J Neurosci. 29, 13823-13836 (2009).
53. Yao, J. & Brinton, R. D. Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease. Adv Pharmacol. 64, 327-371 (2012).
54. Yao, M., Nguyen, T. V. & Pike, C. J. Estrogen regulates Bcl-w and Bim expression: role in protection against beta-amyloid peptideinduced neuronal death. J Neurosci. 27, 1422-1433 (2007).
55. Shulman, L. M. Gender differences in Parkinson's disease. Gend Med. 4, 8-18 (2007).
56. Popat, R. A. et al. Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease. Neurology 65, 383-390 (2005).
57. Abu-Taha, M. et al. Menopause and ovariectomy cause a low grade of systemic inflammation that may be prevented by chronic treatment with low doses of estrogen or losartan. J Immunol. 183, 1393-1402 (2009).
58. Baquet, Z. C., Williams, D., Brody, J. & Smeyne, R. J. A comparison of model-based (2D) and design-based (3D) stereological methods for estimating cell number in the substantia nigra pars compacta (SNpc) of the C57BL/6J mouse. Neuroscience 161, 1082-1090 (2009).